Aspira Women's Health Inc. (AWHL)
D
Pipeline Grade
Financial Position (from SEC Filings)
$3.3M
Cash & Equivalents
$0.4M
Quarterly Burn Rate
28 mo
Est. Cash Runway
$17M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (1)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT05245695 | Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck) | OTHER | Recruiting | 1,200 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.